SKTO. It's understandable the general counsel and puppet

New Post Public Reply Private Reply Replies (0) Message Board
bellsandwhistles BB Player #144
SKTO. It's understandable the general counsel and puppet president Mayor avoided the uncomfortable problem of the troubling 2014 Quarterly during the Q&A by filing the Q1 after the questions were submitted. A typical ploy of the veteran manipulators at iequity + Burke pulling the strings.

Benz sounded like he would rather have been somewhere else, anywhere else, than in this stew. Poor guy; he walked into a den of thieves with his eyes closed. If he walks away from the debacle as did Choo, Allyn, Laughlin, and Jones (wisely so), his exit will confirm SKTO as the fraud that it is. So he stays on with unhappy reluctance and discomfort that his voice and demeanour clearly telegraph.

4Bil (iequity consulting fees conversion $1mil @ 0.0003) + 1.25Bil (est 1 Bil O/S) + 60% of total O/S (iequity preferred conversion) = ca. 8Bil O/S.

iequity will therefore own ca. 7Bil out of the 8Bil shares.

2014 Q1:

"There are currently 5 million shares of the Company issued and outstanding as
Series A Voting Convertible Preferred Shares."

"I Equity Corp. is now the controlling shareholder of the Company."

Both statements above contradicted later in the 2014 Q1:

"The Series A Preferred Share certificates have not yet been issued [...] which is expected to be by May 31, 2014. At that time (i.e., expected May 31), I Equity Corp. will be the controlling shareholder. Henry Jan is the Chief Executive Officer of I Equity Corp."

===
"...there were a total of 737,940,303 common shares issued and outstanding at December 31, 2013."

"...there were a total of 867,940,303 common shares issued and outstanding at March 31, 2014."

They added 130,000,00 to O/S in just 3 months ( 43.3 million per month).

At that rate of accretion, another 87 million shares would be added by May 31, 2014, making O/S 955 million at month end.

Note: Transfer agent gagged.
===
1) "During the quarter ended March 31, 2014, a total of 130,000,000 common shares were issued in conversion of principal amounts due on outstanding convertible promissory notes. As a result, there were a total of 867,940,303 common shares issued and outstanding at March 31, 2014."

2) "The price at which the shares were offered, and the amount actually paid to the issuer: As noted above, the shares issued during the quarter ended March 31, 2014 were issued for principal note conversions of $39,000."

Ergo, $39,000 / 130,000,000 = 0.0003 per share conversion rate.

"Through the quarter ended March 31, 2014, a total $57,375 in principal of the note was transferred to unrelated third parties, leaving a balance due on the original note held by I Equity at $392,625. On January 1, 2014, an additional $600,000 in accrued consulting amounts payable to IEquity Corp. was converted into a promissory note in that amount, which remains outstanding."

As of March 31, 2014, a total of $1,070,466 in short term convertible notes remained outstanding, on which a total of $83,437 had accrued as interest. In addition, two notes in the amount of $30,000 each, dated October 1, 2013 and January 1, 2014, payable for consulting services previously rendered, remained outstanding as long-term liabilities, on which a total of $2,236 in interest had accrued as of March 31, 2014.

$1,070,466 + 83,437 + 60,000 + 2,236 = $1,216,139

3,953,796,666 new shares added by conversion @ 0.0003/sh

4 billion + 1.25 billion A/S = 5.25 billion
===

"For the quarter ended March 31, 2014, the Company has suspended any further accruals under the contractual arrangements with 10 of these
collectives, pending the further development of their business operations."
"PCG is a multi-faceted consulting firm specializing in breeding, mapping and cataloging unique heirloom and land race medical cannabis genetics, with specific emphasis on developing and implementing sustainable, organic, highly efficient cultivation infrastructures, technologies, methodologies and techniques for the growing medical cannabis industry. PCG is comprised of seasoned medical cannabis growers and operators, botanists, scientists, horticulturists, and researchers that collectively have been consulting primarily in California for over 15 years."

"...on May 19, 2014, the Company signed a definitive agreement to acquire Paragon Consulting Group (“PCG”) for 25,000,000 shares of the Company. Monthly revenues of PCG that will flow to SK3 are estimated to be approximately $1.34 million."

There was no evidence presented by SK3 that this firm (PCG) actually exists as described. No information given that could trace its verity. No sane firm with est. $1.34m per months would sell out for a pittance of 25m SKTO shares get into bed with a firm that has fraud written all over it. It would be like boarding a boat that has a rotted hull and is also wanted by the coast guard for smuggling activity. Not to mention, no revenue collected to date, a painful history of accounting sleight of hand if not outright fraud, and an O/S of ca. 8Bil coming down the pike with the conversions.

A definitive agreement means nothing.They've substituted a new con for the old con that had ceased being credible or explainable. In time they'll drop PCG when that ruse outlives its usefulness to them".

===
Q1 2014 Net income before other income (expense) (12,749,036)
Consulting fees 367,655
Scroll down for more posts ▼

Top 10 Most Recent News Articles

China Southern Airlines Marks 70th Anniversary in NYC

Updated Category News Views 3

Taking Flight with Legacy and Tradition Throwing a bash on Times Square isn't just about flash; it's about letting folks know you mean business. And China Southern Airlines has been doing just that for 70 years. Imagine starting from Guangzhou and ending up splashed across New York City's giant LED screens—talk about a journey! From Humble Roots to Global Network...

Continue Reading
Quay Sunglasses: Luxury Looks, Affordable Prices

Updated Category News Views 3

Ah, sunglasses—the quintessential accessory that screams both practicality and style. A million-dollar look without the million-dollar expense? That's where Quay comes in. They've been recognized by Expert Consumers, no less, as some of the best-in-class for affordable luxury eye candy out there—aimed at shoppers who want the designer vibe without the hemorrhaging...

Continue Reading
HONA Faces Legal Heat: Investor Lawsuit Over Losses

Updated Category News Views 6

The Investor Storm Brewing Over Honeywell Aerospace There it is again, another industry heavyweight caught in a dizzying whirlwind of litigation. Honeywell Aerospace Inc. (NASDAQ:HONA), a name as established as an old boot in the business, now faces a class action lawsuit that's got investors frantically dusting off phone numbers for their attorneys. The Messy Allegations...

Continue Reading
CVS Health Under Fire: Fiduciary Duty Breach?

Updated Category News Views 2

CVS Under Regulatory Spotlight for Fiduciary Breaches You'd think by now companies would have their fiduciary ducks in a row. But here we are, with CVS Health Corporation (NYSE: CVS) catching heat from the legal eagles over at Halper Sadeh LLC. The knife’s out for some of the big wigs – apparently, there's chatter they might’ve slipped on their duty to play nice...

Continue Reading
Timur Turlov Leads FIDE with Chess and Digital Focus

Updated Category News Views 4

An Unpredicted Victory in Samarkand Well, color me surprised. Timur Turlov's made waves by clinching the role of FIDE President at the General Assembly in Samarkand. This one's quite the turn for the chess world—Kazakhstan’s own stepping up to run the whole show. This isn't just some ceremonial post either. Turlov, who's been pulling strings over at the Kazakhstan...

Continue Reading
Cut Winter Heating Costs with Townsend's Rebate Help

Updated Category News Views 5

Unseen Perils of Winter Heating in Massachusetts Massachusetts homeowners, listen up. If your heating system is older than the Model T, it's time to rethink your winter strategy. You don't want to be stuck in the cold when the thermometer hits single digits, do you? That's where Townsend comes in, making waves with their rebate assistance program. Navigating the Rebate...

Continue Reading
PACS Group Faces Legal Scrutiny: What to Watch

Updated Category News Views 4

PACS Group: Legal Storm Brewing Welcome to the latest saga in the volatile theater of corporate governance. PACS Group, Inc., ticker symbol NYSE:PACS, is under the microscope, and not for debuting a groundbreaking product or hitting a stock milestone. Nope, instead we've got Halper Sadeh LLC out of New York investigating some possible hanky-panky from PACS directors and...

Continue Reading
Geron Corp Faces Fiduciary Duty Investigation

Updated Category News Views 7

Spotlight on Geron's Corporate Governance: What's Happening? The heat's been turned up on Geron Corporation this week, with Halper Sadeh LLC, an investor rights law outfit, digging into whether some folks at the helm have strayed from their fiduciary duties to the shareholders. Now, if you're holding onto NASDAQ:GERN stock or thinking about diving in, it's high time to...

Continue Reading
Endurance Energy's Modular Tech Revs Up Southeast Asia

Updated Category News Views 3

Modular Solutions Steal the Show in Bangkok When a company draws 59,468 attendees from over 150 countries, folks pay attention—and that was exactly the scene at Gastech 2026 in Bangkok. The name buzzing on many lips? Endurance Energy. These guys showcased a fresh take on energy logistics with their skid-mounted liquefaction tech, turning heads with their Southeast Asia...

Continue Reading
AST SpaceMobile Faces Class Action Over Misstatements

Updated Category News Views 3

What's Going On with AST SpaceMobile? Kicking off with a heavy hitter here, folks. AST SpaceMobile, Inc., trading under NASDAQ:ASTS, is under a securities fraud spotlight. We're talking allegations piled higher than a morning stack of pancakes. If you picked up any ASTS shares between March 4, 2025, and July 15, 2026, you're in on this rough ride. There's a class action...

Continue Reading

Top 5 Most Recently Viewed Articles

Fuel Tech Q1 2025 Financial Summary: Growth and Strategy Insights

Updated Category News Views 210

Fuel Tech Celebrates a Strong Start to 2025 Fuel Tech, Inc. (NASDAQ: FTEK), a leader in technology solutions for emissions control and water treatment, has announced impressive financial results for the first quarter of 2025. The company recorded a remarkable 29% increase in revenue, reaching $6.4 million, compared to $5.0 million in the first quarter of 2024. Key...

Continue Reading
California Resources Corporation Prepares for January Conference

Updated Category News Views 76

California Resources Corporation's Upcoming January Conference California Resources Corporation (NYSE: CRC) is excited to announce its participation in two prominent investor conferences scheduled for January 2026. These events provide a unique platform for CRC's executives to engage with industry stakeholders and discuss the company’s strategic initiatives. Key Events...

Continue Reading
Cyngn Signs Intent to Deliver DriveMod Tuggers in 2025

Updated Category News Views 119

Cyngn's Letter of Intent with a Major Automotive Supplier Today, Cyngn announced that it has entered into a signed Letter of Intent (LOI) to sell and deploy multiple DriveMod Tuggers to a significant automotive supplier, set for implementation in early 2025. This agreement highlights Cyngn's persistent momentum with its Enterprise Autonomy Suite (EAS) automation solutions...

Continue Reading
Iveco Group N.V. Prepares for First Quarter Results Reveal

Updated Category News Views 147

Iveco Group N.V. Plans to Unveil Its 2025 Financial Results Iveco Group N.V. (EXM: IVG) is gearing up to release its financial performance for the first quarter of 2025 on a significant date this May. Scheduled for the 15th, this presentation is highly anticipated as it reflects the company’s market activities and financial health amidst evolving industry conditions....

Continue Reading
Anavex Life Sciences Delivers Promising Q1 Financial Results

Updated Category News Views 112

Anavex Life Sciences Delivers Promising Q1 Financial Results Anavex Life Sciences Corp. (Nasdaq: AVXL), a leading clinical-stage biopharmaceutical company, is making significant strides in developing innovative therapies for neurodegenerative diseases. The company recently presented its financial results for the first quarter of fiscal 2025, which demonstrated the ongoing...

Continue Reading